dr holst glp-1 Dr. Jens Juul Holst: in Modern Medicine | Ep. 03 - The GLP-1 Podcast Show TIME100 Health: Joel Habener, Dan

Izumida, Y

Hospital systems were comparably affected, for example, UPMC out of Pittsburgh posted an even larger loss of about $370 million over the same term, which it attributed to increased medical utilization and pharmacy costs, while Highmark Health - also of Pittsburgh - despite avoiding operational losses, reported a significant decline in operating gains in 2024 relative to 2023, which administrators blame on high prescription drug costs - most notably GLP-1s

This signal comes in the form of luteinizing hormone (LH) produced by the pituitary gland

Both approaches significantly lowered HbA1c levels (weighted mean difference [WMD] 0.75%, 95% CI 0.97 to 0.53) but increased hypoglycemic risk [risk ratio (RR) 7.59, 95% CI 3.3517.17] compared to the unchanged GLP-1RA